These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1552037)
1. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. Rabkin JG; Markowitz JS; Ocepek-Welikson K; Wager SS J Clin Psychopharmacol; 1992 Feb; 12(1):3-10. PubMed ID: 1552037 [TBL] [Abstract][Full Text] [Related]
2. A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials. Coates M; Spanos M; Parmar P; Chandrasekhar T; Sikich L Drug Saf; 2018 May; 41(5):465-471. PubMed ID: 29318515 [TBL] [Abstract][Full Text] [Related]
3. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. Greenhill LL; Vitiello B; Fisher P; Levine J; Davies M; Abikoff H; Chrisman AK; Chuang S; Findling RL; March J; Scahill L; Walkup J; Riddle MA J Am Acad Child Adolesc Psychiatry; 2004 Dec; 43(12):1488-96. PubMed ID: 15564818 [TBL] [Abstract][Full Text] [Related]
4. Interrater agreement and reliability measures of SAFTEE: general inquiry vs. systematic inquiry. Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM Psychopharmacol Bull; 1987; 23(1):97-101. PubMed ID: 3299447 [No Abstract] [Full Text] [Related]
5. General versus specific inquiry with SAFTEE. Levine J; Schooler NR J Clin Psychopharmacol; 1992 Dec; 12(6):448. PubMed ID: 1474186 [No Abstract] [Full Text] [Related]
6. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Levine J; Schooler NR Psychopharmacol Bull; 1986; 22(2):343-81. PubMed ID: 3774930 [No Abstract] [Full Text] [Related]
8. Side effect assessment with SAFTEE: pilot study of the instrument. Rabkin JG; Markowitz JS Psychopharmacol Bull; 1986; 22(2):389-96. PubMed ID: 3774932 [No Abstract] [Full Text] [Related]
9. Adverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns. Hughes S; Cohen D; Johnson R Int J Risk Saf Med; 2016 Aug; 28(2):101-14. PubMed ID: 27567767 [TBL] [Abstract][Full Text] [Related]
10. [Psychopharmacotherapy in somatic diseases -- treatment principles in daily medical routine]. Rothenhäusler HB; Kapfhammer HP Wien Med Wochenschr; 2005 Jul; 155(13-14):303-14. PubMed ID: 16092037 [TBL] [Abstract][Full Text] [Related]
11. Reliability and validity of SAFTEE: preliminar analyses. Guy W; Wilson WH; Brooking B; Manov G; Fjetland O Psychopharmacol Bull; 1986; 22(2):397-401. PubMed ID: 3774933 [No Abstract] [Full Text] [Related]
13. Some problems in the conduct of psychotropic drug trials (a review). Doongaji DR; Parikh MD J Postgrad Med; 1983 Apr; 29(2):67-74. PubMed ID: 6631765 [No Abstract] [Full Text] [Related]
14. Psychotropic drugs and paediatrics: a critical need for more clinical trials. Tishler CL; Reiss NS J Med Ethics; 2012 Apr; 38(4):250-2. PubMed ID: 22048850 [TBL] [Abstract][Full Text] [Related]
15. Intra-interrater reliability of SAFTEE using videotape interviews and clinical trial data. Guy W; Wilson WH; Brooking B; Fjetland OK Psychopharmacol Bull; 1987; 23(1):93-6. PubMed ID: 3299446 [No Abstract] [Full Text] [Related]
16. Psychotropic drugs and impairment of psychomotor functions. Penttilä A; Lehti H; Lönnqvist J Psychopharmacologia; 1975 Jul; 43(1):75-80. PubMed ID: 1099606 [TBL] [Abstract][Full Text] [Related]
17. Distress with medication side effects among persons with severe mental illness. Covell NH; Weissman EM; Schell B; McCorkle BH; Summerfelt WT; Weiden PJ; Essock SM Adm Policy Ment Health; 2007 Sep; 34(5):435-42. PubMed ID: 17653845 [TBL] [Abstract][Full Text] [Related]
18. [Carpipramine, a specific psychotropic drug between neuroleptics and anti-depressive drugs]. Deniker P; Lôo H; Zarifian E; Garreau G; Benyacoub A; Roux JM Ann Med Psychol (Paris); 1978 Nov; 136(9):1069-80. PubMed ID: 378058 [No Abstract] [Full Text] [Related]